We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo

Product News   Jan 15, 2020

 
ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo
FURTHER INFORMATION
 
 
 

Related Product News

Horizon Discovery and Mammoth Biosciences Collaborate To Improve Biotherapeutic Production

Product News

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

READ MORE

Agreement to Commercialize CRISPR Tools and Reagents

Product News

ERS Genomics Limited has signed an agreement with New England Biolabs (NEB®), granting NEB rights to sell CRISPR/Cas9 tools and reagents.

READ MORE

Streamlining CRISPR With Predesigned Synthetic sgRNAs

Product News

Horizon has announced the addition of predesigned synthetic single guide RNA (sgRNA) to its product range.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE